Cure8 research brief
Depression and GI diseases often co-occur; knowing which tends to appear first — and that this varies by subtype — can help clinicians prioritize screening and integrated care.
Patients with IBS may especially benefit from early mental-health assessment, while people with Crohn's disease may need attention for mental-health after GI diagnosis.
Clinicians (gastroenterologists, primary care, mental-health providers), researchers studying IBD-psychiatric comorbidity or EHR-based epidemiology, and adult patients with IBS, Crohn's disease, or UC.
This analysis suggests that the temporal relationship between depression and GI disease differs by GI subtype. For IBS patients, depression often came first; for Crohn's disease, GI diagnoses more often preceded depression.
The study used EHR-derived diagnosis timing and statistical models to estimate bidirectional hazard ratios and attempted replication across centers. Antidepressant exposure was reported to be linked with reduced subsequent GI diagnosis rates in the dataset, but this is an association from observational data, not proof of causation.
Clinical implications: Results support increased attention to mental-health screening and integrated care in patients with or at risk for GI disorders, and suggest subtype-specific patterns that could inform surveillance and research.
However, decisions about treatment or screening should rely on clinical judgment and guideline recommendations, not on a single observational study.
This is a retrospective EHR-based observational study that reports associations and temporal ordering of recorded diagnoses; it cannot prove causation. Diagnosis timing in EHRs can be influenced by access to care, coding practices, and symptom recognition. The abstract-level summary was used to prepare this brief.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Depression is common in people with IBD and can worsen quality of life and disease outcomes. This trial explores whether mirtazapine—an antidepressant thought to have favorable gastrointestinal tolerability—can be...
The trial could show whether a smart-label app plus clinician alerts improves medication adherence and downstream clinical outcomes for people with Crohn's disease or ulcerative colitis starting oral or subcutaneous...
Researchers are exploring ways to prioritize who needs colonoscopy sooner; adding TCM features to prediction models might change triage performance. Patients and clinicians interested in pre-endoscopic risk tools or...
